Potassium Carbonate → HCID 53251705, compound
Reaction equation
C([O:4][CH2:5][C:6](=[O:30])[NH:7][C:8]1[S:9][C:10]([C:13]2[CH:18]=[CH:17][CH:16]=[C:15]([NH:19][C:20]3[N:25]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:23]=[CH:22][N:21]=3)[CH:14]=2)=[CH:11][N:12]=1)(=O)C.C(=O)([O-])[O-].[K+].[K+]>CO>[OH:4][CH2:5][C:6]([NH:7][C:8]1[S:9][C:10]([C:13]2[CH:18]=[CH:17][CH:16]=[C:15]([NH:19][C:20]3[N:25]=[C:24]([C:26]([F:27])([F:28])[F:29])[CH:23]=[CH:22][N:21]=3)[CH:14]=2)=[CH:11][N:12]=1)=[O:30]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of 2-oxo-2-{[5-(3-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]amino}ethyl acetate 1 (8.3 mg, 0.019 mmol) in MeOH (1 mL) at room temperature, under nitrogen, was added potassium carbonate (5.25 mg, 0.038 mmol). The mixture was stirred at room temperature for 18 hours. The mixture was filtered through celite and concentrated to dryness. The product was purified by column chromatography on silica gel (ethanol/ethyl acetatee) to afford 2-hydroxy-N-[5-(3-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]acetamide (2.3 mg, 30.7%) as a beige solid. APCI [M+H]+ m/z 396.0. 1H NMR (400 MHz, DMSO): δ 11.86 (s, 1H); 10.31 (s, 1H); 8.86 (d, J=4.9 Hz, 1H); 8.12 (s, 1H); 7.82 (s, 1H); 7.65 (d, J=8.0 Hz, 1H); 7.42-7.23 (m, 3H); 5.55 (t, J=6.3 Hz, 1H); 4.18 (d, J=6.0 Hz, 2H). rhSYK activity=+++
Workup
- filtrationThe mixture was filtered through celite and
- concentrationconcentrated to dryness
- customThe product was purified by column chromatography on silica gel (ethanol/ethyl acetatee)
Sources & evidence
- ORD record
- ord-7534298387a34f85816b498766085623
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08735417B2
Reaction notes
Loading…